Cool. So then these companies should have nothing to fear.
This isn't going to help India or anyone in the short term and there'll be more than enough doses for every person on Earth by next year. Why should they not retain the IP rights to make a profit on new generations that need to be vaccinated or potential booster shots? The manufacturing capacity will have been built up so scarcity won't be a problem at that point.
If you held a firm conviction that in the near future you'd be able to act on the IP without being in violation, would you be more motivate to progress toward doing so more swiftly?
As a patent holder, would you feel more secure that you could issue cease and desist notices and peruse damages after the waiver is lifted?
Why not? I’m not hearing a clear argument or evidence to support that withholding the patent recipe wouldn’t save millions of lives?
India now has a very high number of cases. As it stands now, your argument just sounds to me like:
“yes human lives, but... profit“.
Please could you elaborate on your argument and/or provide examples of what you’re describing happening in other cases?
This is about mRNA vaccines, but similar things exist for viral vector vaccines as well. Technology transfer, bioreactor bags, fill-finish capacity, all of these things are bottlenecked till next year basically.